DELMAR PHARMACEUTICALS (DMPI) analyst actions
Rating and price-target actions on DMPI in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the DMPI overview →
No DMPI analyst action events in the measured window.
Nothing matched in the current window — the DMPI overview has every event we measure for this name.
Get an email when DMPI moves on news →Keep exploring
More DMPI: earnings → · SEC filings → · DMPI overview →
Other Healthcare names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| CAMBREX (CBM) | 505 | 0.00% | 49% |
| Celyad Oncology SA - American Depositary Shares (CYAD) | 504 | 0.00% | 41% |
| Supernus Pharmaceuticals, Inc. (SUPN) | 504 | -0.09% | 42% |
| CORINDUS VASCULAR ROBOTICS INC (CVRS) | 503 | -0.65% | 37% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.